Asserter profile

CLEVELAND MEDICAL DEVICES INC.

operating company3 patents now3 ever0 cases filed during tenure3 connections

PTAB exposure

3of this entity’s patents have been challenged at PTAB (3 total proceedings). 1 had claims invalidated. 2 survived a challenge.

Final written decisions are public record. The invalidation grounds usually carry over as § 102 / § 103 ammunition in district court — see IPR estoppel.

Two-hop network

Edges marked ⚖️ overlap with at least one infringement suit filed during the receiving entity’s tenure with the patent. Bold-bordered = this entity. Red = NPE; orange = shell LLC; green = defensive aggregator; blue = operating company.

flowchart LR
    Ncleveland_medical_devices["CLEVELAND MEDICAL DEVICES INC."]
    Nbishop_dan_kayyali_hani_kolkowski_brian_m["BISHOP, DAN; KAYYALI, HANI; KOLKOWSKI,…"]
    Nhani_kayyali_robert_schmidt_mohammad_modarres_zadeh_brian_ko["Hani Kayyali, Robert Schmidt, Mohammad…"]
    Nbishor_daniel_kayyali_hani_kolkowski_brian_m["BISHOR, DANIEL; KAYYALI, HANI; KOLKOWSK…"]
    Nbishop_dan_kayyali_hani_kolkowski_brian_m -->|"2019 · Assignment of Assignors Interest · 11786680"| Ncleveland_medical_devices
    Nhani_kayyali_robert_schmidt_mohammad_modarres_zadeh_brian_ko -->|"2023 · Assignment of Assignors Interest · 11872029"| Ncleveland_medical_devices
    Nbishor_daniel_kayyali_hani_kolkowski_brian_m -->|"2018 · Assignment of Assignors Interest · 11857333"| Ncleveland_medical_devices
    classDef focal fill:#fef3c7,stroke:#92400e,stroke-width:3px,color:#1c1917
    classDef npe fill:#fee2e2,stroke:#be123c,stroke-width:2px,color:#1c1917
    classDef shell fill:#fed7aa,stroke:#9a3412,stroke-width:2px,color:#1c1917
    classDef defensive fill:#dcfce7,stroke:#15803d,stroke-width:2px,color:#1c1917
    classDef operating fill:#e0f2fe,stroke:#075985,stroke-width:1px,color:#1c1917
    class Ncleveland_medical_devices focal

Patents currently held (3)

Connected entities (3)

Correspondent attorneys (2)

Attorneys / firms recorded with USPTO when this entity received a patent. Recurrence is the signal — many firms do both NPE and operating-company patent work, so a single appearance doesn’t mean much.